- •
Hyperglycemic emergencies are life-threatening complications of diabetes.
- •
This article reviews diabetic ketoacidosis and hyperglycemic hyperosmolar state addressing historical context, epidemiology, clinical features, and guidelines for management.
Management of Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State
Section snippets
Key points
Historical review of diabetic comas
The first detailed clinical description of diabetic coma in an adult patient with severe polydipsia, polyuria, and a large amount of glucose in the urine followed by progressive decline in mental status and death was reported by August W. von Stosch in 1828.5 This publication was followed by several case reports describing young and adult patients with newly diagnosed or with established diabetes who presented with an abrupt clinical course of excessive polyuria, glycosuria, coma, and death.6, 7
Epidemiology
Although DKA occurs more commonly in patients with autoimmune T1D, the cumulative number of cases of DKA reported in patients with T2D represents at least one-third of all cases.22 Global epidemiologic studies have reported on the incidence of DKA among patients with T1D. An analysis from the Prospective Diabetes Registry in Germany including 31,330 patients reported a DKA admission rate of 4.81 per 100 patient-years (95% confidence interval [CI], 4.51–5.14).23 Individuals with the highest risk
Precipitating cause
The most common precipitating causes of DKA reported in different epidemiologic studies worldwide are shown in Table 1. DKA is the initial presentation of diabetes in approximately 15% to 20% of adults and in approximately 30% to 40% of children with T1D.4, 37, 38 Infection is the most common cause of DKA around the world; however, poor adherence to insulin treatment is the most common precipitating cause of DKA in young patients with T1D and in inner city populations in the United States.39, 40
Pathophysiology
The 2 most important pathophysiologic mechanisms for DKA and HHS are significant insulin deficiency and increased concentration of counterregulatory hormones such as glucagon, catecholamines, cortisol, and growth hormone (Fig. 1).62, 63, 64 The insulin deficiency of DKA can be absolute in patients with T1D or relative as observed in patients with T2D in the presence of stress or intercurrent illness.65 Insulin deficiency coupled with increased counterregulatory hormones lead to increased
Signs and Symptoms
Patients with DKA often present following a short clinical course characterized by fatigue and classic symptoms of hyperglycemia: polyuria, polydipsia, and weight loss. Gastrointestinal complaints are common with diffuse abdominal pain reported in 46% of patients and nausea and vomiting in up to two-thirds of patients.42 About one-half of patients present with lethargy and stupor, but less than 25% present with loss of consciousness.1 On physical examination, patients often present with signs
Symptoms and Signs
The majority of patients with HHS present with a history of polyuria, polydipsia, weakness, blurred vision, and progressive decline in mental status.50, 83 The typical patient with HHS is older than 60 years of age with an infection or acute illness who has delayed seeking medical attention. On physical examination, similar to DKA, patients with HHS frequently have clear signs of dehydration, dry mucous membranes and poor skin turgor, or hypotension.50
Laboratory Findings
The diagnostic criteria for HHS includes a
Common laboratory pitfalls
Patients with DKA frequently present with significant leukocytosis with white cell counts in the 10,000 to 15,000 mm3 range. A leukocyte count of greater than 25,000 mm3 or the presence of greater than 10% neutrophil bands is seldom seen in the absence of bacterial infection.64, 84 In ketoacidosis, leukocytosis is attributed to stress, dehydration, and demargination of leukocytes.
The admission serum sodium may be low because of the osmotic flux of water from the intracellular to the
Management of hyperglycemic crises
The American Diabetes Association algorithm for the management of hyperglycemic emergencies is shown in Fig. 2.1 Similar therapeutic measures are recommended for the treatment of DKA and HHS. In general, treatment goals include correction of dehydration, hyperglycemia, hyperosmolality, electrolyte imbalance, and increased ketonemia, and the identification and treatment of precipitating event(s). The average time to resolution is between 10 and 18 hours for DKA89, 90 and approximately 9 and
Fluid therapy
Intravenous (IV) fluids are a critical aspect of treatment of hyperglycemic emergencies. Treatment with IV fluids alone expands intravascular volume, restores renal perfusion, and reduces insulin resistance by decreasing circulating counterregulatory hormone levels.62 Isotonic saline (0.9% NaCl) is the preferred solution and is given at an initial rate of 500 to 1000 mL/h during the first 2 to 4 hours. A study comparing 2 IV fluid regimens with sodium chloride and lactate ringers found no
Transition to maintenance insulin regimen
Resolution of DKA is defined when glucose levels are lower than 250 mg/dL, venous pH is greater than 7.30, there is a normal anion gap, and serum bicarbonate is 18 mEq/L or greater.1 HHS resolution is achieved when effective serum osmolality is less than 310 mOsm/kg and the glucose level is 250 mg/dL or less (13.8 mmol/L) in a patient who has recovered mental alertness and regaining of mental status.1, 97
Because of the short half-life of intravenous insulin (<10 minutes),109 abrupt cessation of
Complications
Hypoglycemia is the most common complication during treatment, reported in 5% to 25% of patients with DKA.1, 4, 105 Lack of frequent monitoring and the failure to reduce insulin infusion rate and/or to use dextrose-containing solutions when blood glucose levels are less than 200 mg/dL are the most important risk factors associated with hypoglycemia during insulin treatment. Many patients with hypoglycemia do not experience adrenergic manifestations of sweating, nervousness, fatigue, hunger, and
Prevention
Medication noncompliance is a leading cause of DKA among both newly diagnosed and recurrent episodes of DKA.39, 40, 41 The mean cost of hospitalization is about $7500.40 In one-half of such episodes, patients report an inability to afford medication or to pay for transportation as the reason why medication was discontinued.41 Development of system-wide changes such as assistance programs to provide insulin to patients and reduce lapses in treatment may be a cost-effective way to reduce the rate
References (123)
- et al.
Characteristics and outcomes of the hyperglycemic hyperosmolar non-ketotic syndrome in a cohort of 51 consecutive cases at a single center
Diabetes Res Clin Pract
(2011) Hyperglycemic hyperosmolar state: an emerging pediatric problem
J Pediatr
(2010)- et al.
Hyperosmolar hyperglycemic crisis: an acute life-threatening event in children and adolescents with type 2 diabetes mellitus
Endocr Pract
(2005) - et al.
Diabetic ketoacidosis at diabetes onset: still an all too common threat in youth
J Pediatr
(2013) - et al.
Abdominal pain in patients with hyperglycemic crises
J Crit Care
(2002) - et al.
A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United States
J Clin Epidemiol
(2003) - et al.
Differential effects of antipsychotic agents on the risk of development of type 2 diabetes mellitus in patients with mood disorders
Clin Ther
(2003) - et al.
Atypical antipsychotics and hyperglycemic emergencies: multicentre, retrospective cohort study of administrative data
Schizophr Res
(2014) SGLT-2 inhibition and glucagon: cause for alarm?
Trends Endocrinol Metab
(2015)- et al.
Oxidative stress, insulin signaling, and diabetes
Free Radic Biol Med
(2011)
The association of oxidative stress and pro-inflammatory cytokines in diabetic patients with hyperglycemic crisis
J Diabetes Complications
Oxidative stress and inflammation in hyperglycemic crises and resolution with insulin: implications for the acute and chronic complications of hyperglycemia
J Diabetes Complications
Diabetic ketoacidosis and infection: leukocyte count and differential as early predictors of serious infection
Am J Emerg Med
Potassium in severe diabetic ketoacidosis
Am J Med
Differences in metabolic and hormonal milieu in diabetic- and alcohol-induced ketoacidosis
J Crit Care
Impact of a hyperglycemic crises protocol
Endocr Pract
Resource utilization in treatment of diabetic ketoacidosis in adults
Am J Med Sci
Sodium bicarbonate therapy in severe diabetic ketoacidosis
Am J Med
Failure of adjunctive bicarbonate to improve outcome in severe pediatric diabetic ketoacidosis
Ann Emerg Med
Hyperglycemic crises in adult patients with diabetes
Diabetes Care
The hyperosmolar hyperglycemic syndrome
Diabetes Rev
Hyperglycemic crises in urban blacks
Arch Intern Med
Versuch einer Pathologie und Therapie des Diabetes Mellitus
Case of infantile diabetes
Prov Med Surg J
Case of acute diabetes
Prov Med Surg J
Cases of diabetes
Prov Med J Retrosp Med Sci
Zur lehre vom diabetes mellitus
Dtsch Arch Klin Med
Adolf Kussmaul (1822-1902)–Country Doctor to Clinical Professor
JAMA
Ueber die Ursachen der pathologischen ammoniakausscheidung beim diabetes mellitus und des coma diabeticum
Arch Exp Pathol Pharmakol
Ueber eine neue linksdrehende saure (pseudo-oxybuttersaure)
Zeitschr f Biologie
The Bradshawe lecture on diabetic coma
Br Med J
Pancreatic extracts in the treatment of diabetes mellitus: preliminary report
Can Med Assoc J
Diabetic coma and diabetic mortality rates
Can Med Assoc J
Fatal diabetic ketoacidosis: major causes and approaches to their prevention
Diabetes Care
Diabetic ketoacidosis
N Engl J Med
Detailed diagnosis and procedures: National Discharge Survey, 1995. National Center for Health Statistics
Vital Health Stat 13
Therapy of severe diabetic ketoacidosis. Zero-mortality under very-low-dose insulin application
Diabetes Care
Hyperosmolar hyperglycemic state: a historic review of the clinical presentation, diagnosis, and treatment
Diabetes Care
Ketoacidosis occurs in both type 1 and type 2 diabetes–a population-based study from Northern Sweden
Diabet Med
Hospital admission for diabetic ketoacidosis or severe hypoglycemia in 31,330 young patients with type 1 diabetes
Eur J Endocrinol
Rates of diabetic ketoacidosis: international comparison with 49,859 pediatric patients with type 1 diabetes from England, Wales, the U.S., Austria, and Germany
Diabetes Care
Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry
Diabetes Care
Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis
Diabet Med
Diabetic ketoacidosis: risk factors, mechanisms and management strategies in sub-Saharan Africa: a review
East Afr Med J
Prognostic factors in the diabetic hyperosmolar state
J Am Geriatr Soc
Persisting mortality in diabetic ketoacidosis
Diabet Med
Characteristics of diabetic ketoacidosis in older versus younger adults
J Am Geriatr Soc
Risk of death following admission to a UK hospital with diabetic ketoacidosis
Diabetologia
Long-term mortality risk after hyperglycemic crisis episodes in geriatric patients with diabetes: a national population-based cohort study
Diabetes Care
Cited by (133)
Hyperosmolar Hyperglycemic State
2023, Emergency Medicine Clinics of North AmericaCriteria air pollutants and diabetes mortality classified by different subtypes and complications: A nationwide, case-crossover study
2023, Journal of Hazardous MaterialsDiabetic ketoacidosis
2023, Disease-a-MonthCitation Excerpt :Dextrose-containing fluid is continued to keep blood glucose between 8.4-14 mmol/L (150-250 mg/dL). This allows for the prevention of hypoglycemia with continued insulin infusion to correct the ketoacidosis as it takes longer to resolve.1,2,5,6,12,30,39–41 Fluid resuscitation should be carefully monitored in several patient populations such as the elderly, patients with heart failure, and end-stage kidney disease.